These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7829675)

  • 1. Decreased mucosal interleukin-4 (IL-4) production in gut inflammation.
    Karttunnen R; Breese EJ; Walker-Smith JA; MacDonald TT
    J Clin Pathol; 1994 Nov; 47(11):1015-8. PubMed ID: 7829675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine.
    MacDonald TT; Hutchings P; Choy MY; Murch S; Cooke A
    Clin Exp Immunol; 1990 Aug; 81(2):301-5. PubMed ID: 2117510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrinsic hyperreactivity of mucosal T cells to interleukin-2 in pediatric Crohn's disease.
    Kugathasan S; Willis J; Dahms BB; O'Riordan MA; Hupertz V; Binion DG; Boyle JT; Fiocchi C
    J Pediatr; 1998 Nov; 133(5):675-81. PubMed ID: 9821428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
    Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
    J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of interleukin-2-producing intestinal CD4+ T cells in inflammatory bowel disease.
    Kusugami K; Matsuura T; West GA; Youngman KR; Rachmilewitz D; Fiocchi C
    Gastroenterology; 1991 Dec; 101(6):1594-605. PubMed ID: 1683326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-2 production in pediatric inflammatory bowel disease: evidence for dissimilar mononuclear cell function in Crohn's disease and ulcerative colitis.
    Gurbindo C; Sabbah S; Menezes J; Justinich C; Marchand R; Seidman EG
    J Pediatr Gastroenterol Nutr; 1993 Oct; 17(3):247-54. PubMed ID: 8271122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imbalance of the interleukin 1 system in colonic mucosa--association with intestinal inflammation and interleukin 1 receptor antagonist [corrected] genotype 2.
    Andus T; Daig R; Vogl D; Aschenbrenner E; Lock G; Hollerbach S; Köllinger M; Schölmerich J; Gross V
    Gut; 1997 Nov; 41(5):651-7. PubMed ID: 9414973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
    Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
    Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of alpha 4 beta 7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation.
    Meenan J; Spaans J; Grool TA; Pals ST; Tytgat GN; van Deventer SJ
    Gut; 1997 Feb; 40(2):241-6. PubMed ID: 9071939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin G (IgG), IgG1, and IgG2 determinations from endoscopic biopsy specimens in control, Crohn's disease, and ulcerative colitis subjects.
    Rüthlein J; Ibe M; Burghardt W; Mössner J; Auer IO
    Gut; 1992 Apr; 33(4):507-12. PubMed ID: 1582596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa.
    Breese E; Braegger CP; Corrigan CJ; Walker-Smith JA; MacDonald TT
    Immunology; 1993 Jan; 78(1):127-31. PubMed ID: 8436398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease.
    Breese EJ; Michie CA; Nicholls SW; Murch SH; Williams CB; Domizio P; Walker-Smith JA; MacDonald TT
    Gastroenterology; 1994 Jun; 106(6):1455-66. PubMed ID: 8194690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of interleukin 17 in inflammatory bowel disease.
    Fujino S; Andoh A; Bamba S; Ogawa A; Hata K; Araki Y; Bamba T; Fujiyama Y
    Gut; 2003 Jan; 52(1):65-70. PubMed ID: 12477762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunohistological study of T-lymphocytes (total and helper) and B-lymphocytes of the colonic mucosa in children with Crohn's disease and non-specific ulcerative colitis].
    Rodrigues M; Zerbini MC; Barbieri D
    Arq Gastroenterol; 1998; 35(3):223-36. PubMed ID: 10029869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of interleukin-1 receptor antagonist to mucosal inflammation in inflammatory bowel disease.
    Hyams JS; Fitzgerald JE; Wyzga N; Muller R; Treem WR; Justinich CJ; Kreutzer DL
    J Pediatr Gastroenterol Nutr; 1995 Nov; 21(4):419-25. PubMed ID: 8583293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease.
    Kugathasan S; Saubermann LJ; Smith L; Kou D; Itoh J; Binion DG; Levine AD; Blumberg RS; Fiocchi C
    Gut; 2007 Dec; 56(12):1696-705. PubMed ID: 17682002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective resistance of mucosal T-cell activation to immunosuppression in Crohn's disease.
    Matsuura T; West GA; Levine AD; Fiocchi C
    Dig Liver Dis; 2000; 32(6):484-94. PubMed ID: 11057923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn's disease.
    Breese EJ; Michie CA; Nicholls SW; Williams CB; Domizio P; Walker-Smith JA; MacDonald TT
    Aliment Pharmacol Ther; 1995 Oct; 9(5):547-52. PubMed ID: 8580276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diversion of intestinal flow decreases the numbers of interleukin 4 secreting and interferon gamma secreting T lymphocytes in small bowel mucosa.
    Schmit A; Van Gossum A; Carol M; Houben JJ; Mascart F
    Gut; 2000 Jan; 46(1):40-5. PubMed ID: 10601053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune system alterations in patients with inflammatory bowel disease during remission.
    Sventoraityte J; Zvirbliene A; Kiudelis G; Zalinkevicius R; Zvirbliene A; Praskevicius A; Kupcinskas L; Tamosiūnas V
    Medicina (Kaunas); 2008; 44(1):27-33. PubMed ID: 18277086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.